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ABSTRACT
Lymphomas of the bladder are rare lesions, representing approximately 0.2% of the primary
neoplastic lesions and approximately 1.8% of the secondary lesions in this organ.
The authors report the case of a 41-year old patient with secondary lymphoma of the bladder
occurring 2 years after treatment for non-Hodgkin lymphoma, diagnosed by biopsy of cervical lymph
node, and analyze the clinical and prognostic aspects of bladder lymphomas.
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INTRODUCTION
Lymphomas of the bladder are rare lesions,
representing approximately 0.2% of the primary
neoplastic lesions and approximately 1.8% of the
secondary lesions in this organ (1).
Patients with bladder lymphomas can be
divided into 3 groups, according to their clinical
presentation: 1) primary cases in bladder, 2) cases
occurring in bladder as a manifestation of systemic
disease, and 3) secondary cases, with clinical history
of malignant lymphoma recurring in bladder. In the
latter case, the main sites of primary involvement are
peripheral lymph nodes, bone marrow and spleen (2).
The authors report the case of a 41-year old
patient with secondary lymphoma of the bladder
occurring 2 years after treatment for “non-Hodgkin”
lymphoma, diagnosed by biopsy of cervical lymph node.
CASE REPORT
Male, 41-year old, asymptomatic patient was
referred for urological evaluation with ultrasound
revealing a tumor in the bladder lateral wall. There
was a previous history of non-Hodgkin lymphoma,
diagnosed through biopsy of cervical lymph node and
treated with chemotherapy. Patient reported that the
disease was in remission for 2 years.
An abdominal computerized tomography was
performed (Figure-1), which confirmed the ultrasound
Figure 1 – Pelvic computerized tomography, showing tumor in
right lateral wall of the bladder.
Case Report
International Braz J Urol
Official Journal of the Brazilian Society of Urology
Vol. 30 (6): 499-501, November - December, 2004
500
NON-HODGKIN LYMPHOMA OF THE BLADDER
findings. He underwent a cystoscopy, which showed a
bulging in the right lateral wall of the bladder, without
involving the mucosal surface, which presented normal
aspect. The ureteral meatus were normal.
We performed a transurethral resection of the
lesion. The pathological examination revealed a
lymphoproliferative process with follicular pattern,
characterizing a non-Hodgkin lymphoma of the
bladder (Figure-2). The immunohistochemical analysis
was positive to CD20, characterizing B-lymphocytes
(Figure-3), and to bcL-2 protein (Figure-4),
characterizing a follicular lymphoma. The patient was
referred for adjuvant chemotherapy.
COMMENTS
Among cases of bladder lymphoma,
approximately 17% occur in primary form, 47% in
non-localized form, and 36% in secondary form (2).
MALT-type lymphomas (mucosa associated lymphoid
tissue) are the most common form of primary
involvement of the bladder. The prognosis of these
cases is usually good, and most series do not report
deaths associated with the disease. The disease is 6.5
times more frequent in women and predominates in
patients with mean age of 64 years old (20 to 85) (3).
Lesions can be single or multiple, and irritative
bladder symptoms may occur. Approximately 20%
may present a history of chronic cystitis (2).
Cases of non-localized bladder lymphoma
predominate in men, and tend to present fewer
symptoms relative to bladder involvement. These
patients usually present abdominal pain. Approximately
half the patients can present ureteral obstruction. Mean
survival in these cases is 9 years (2).
The occurrence of secondary involvement of
the bladder by a systemic lymphoma is more common
than primary involvement. Necropsy studies show that
approximately 10 to 20% of cases of systemic non-
Hodgkin lymphoma can involve the bladder
secondarily (1,3). Normally, such patients die due to
disseminated disease, which frequently involves other
urogenital sites or associated with massive pelvic
involvement.
In the series by Kempton et al. (2), 10 of 13
patients presented symptoms related to involvement
Figure 2 – Histological analysis of bladder wall showing
lymphoproliferative process with follicular pattern (HE, X250).
Figure 3 – Immunohistochemical positivity to CD20 (X400).
Figure 4 – Immunohistochemical positivity to bcL-2 protein,
characterizing follicular lymphoma (X200).
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of the urinary tract, and 30% presented associated
ureteral obstruction. The mean interval between
diagnosis and secondary involvement of the bladder
was 4.5 years (0.3 to 12 years), and the initial site of
lymphomas, in decreasing frequency, were peripheral
lymph nodes, bone marrow, spleen, orbit, lungs and
palate. The patient in the present case presented initial
involvement of lymph nodes from the cervical region.
Usually, patients with secondary involvement
of the bladder are treated with salvage chemotherapy,
and mean survival can range from 5 days to 8 years
(median 0.58 years), thus constituting the group with
poorer prognosis (2).
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